MDXHNasdaqServices-Medical Laboratories
MDxHealth SA
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 3, 2026
$0.18−0.02 (-11.33%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$3.8268 (−95.43%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
MDxHealth SA grew revenue 19.8% to $107.88M over fiscal 2025. Free cash flow was -$3.35M.
Revenue
$107.88M
+19.8% vs. a year earlier
Operating income
-$14.41M
FY2025
Free cash flow
-$3.35M
FY2025
EPS, diluted
-$0.67
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $107.88M
- Net income
- -$33.52M
- EPS, diluted
- -$0.67
- Free cash flow
- -$3.35M
Seven years at a glance
Fiscal years 2019 to 2025, USD
Revenue
$107.88M+19.8% YoY
Gross profit
$69.63M+26.3% YoY
Operating income
-$14.41M
Net income
-$33.52M
EPS, diluted
-$0.67
Free cash flow
-$3.35M
Reported period